Table 1. Demographic and clinical characteristics of study participants.

	Schizophrenia	Controls
Age (Mean ± SD)b	45.1 ± 12.3	51.7 ± 8.8
Genderc	58% male	75% male
Medication	All medicateda	N/A
Length of disease  (years)	6.4 ± 3.4	N/A
Symptoms	All in relative symptomatic remission	No history of mental disorders

^aSchizophrenia patients were prescribed anti-psychotic medication, including Olanzapine, Risperidone, Aripiprazole, Perphenazine, Fluphenazine, Ziprasidone, Haloperidol and Quetiapine.

^bDifference between age distributions of schizophrenia and control groups is not significant (p = 0.09) using a two-sided Student t-test at a 95% confidence interval.

^cDifference between gender distributions of schizophrenia and control groups is not significant (p = 0.31) using Fisher’s exact test.